It was found that triple therapy can increase the level of CCL 28 and the number of CD 8+ and CD 4+ T cells in peripheral blood and reduce the level of betacellulin, which inhibits tumor angiogenesis and progression. This evidence concerns the gene BTC and neoplasm.